文献速递妇科

微囊性伸长和碎片(MELF)侵袭模式:PORTEC-1和-2试验中的分子特征与预后意义

Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.
PubMed 文献 · Gynecol Oncol · 2022-07-13

在PORTEC-1/-2试验的979例早期中/高危子宫内膜癌中,13.1%存在MELF侵袭,其与低级别、深肌层浸润和显著脉管间隙浸润相关,85.6%为NSMP型。MELF阳性者复发风险低于阴性者(4.9% vs 12.7%,p=0.026),但校正临床病理和分子因素后无独立影响(HR 0.65,p=0.30)。作者认为不推荐常规评估MELF侵袭。

要点

  • MELF侵袭见于13.1%的早期中/高危子宫内膜癌,常为低级别NSMP型。
  • MELF阳性者复发率4.9% vs 阴性者12.7%(p=0.026),但校正后无独立预后影响(HR 0.65,p=0.30)。
  • 作者认为常规评估MELF侵袭无临床意义,不推荐。

核心结论

  • MELF侵袭对早期子宫内膜癌复发风险无独立影响,且常见于低级别NSMP肿瘤。
  • 作者认为常规评估MELF侵袭无临床意义,不推荐。

研究设计与样本

  • 对参与PORTEC-1/-2试验的1141例中/高危子宫内膜癌中的979例(85.8%)进行单张全肿瘤切片回顾。
  • 比较MELF侵袭阳性与阴性病例的临床病理和分子特征。
  • 采用Kaplan-Meier法、log-rank检验和Cox比例风险模型进行时间-事件分析。

主要发现

  • MELF侵袭见于128例(13.1%),与1-2级组织学、深肌层浸润和显著脉管间隙浸润(LVSI)相关。
  • 85.6%的MELF侵袭阳性肿瘤为无特定分子谱(NSMP)子宫内膜癌。
  • NSMP型MELF侵袭阳性肿瘤中,CTNNB1野生型占92.2%,KRAS突变占24.4%。
  • MELF侵袭阳性者复发风险低于阴性者(4.9% vs 12.7%,p=0.026)。
  • 校正临床病理和分子因素后,MELF侵袭对复发风险无独立影响(HR 0.65,p=0.30)。

临床怎么用

  • 作者认为常规评估MELF侵袭无临床意义,不推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Microcystic, elongated fragmented (MELF) pattern of myometrial invasion is a distinct histologic feature occasionally seen in low-grade endometrial carcinomas (EC). The prognostic relevance of MELF invasion was uncertain due to conflicting data, and it had not yet appropriately been studied in the context of the molecular EC classification. We aimed to determine the relation of MELF invasion with clinicopathological and molecular characteristics, and define its prognostic relevance in early-stage low/intermediate risk EC. METHODS: Single whole tumor slides of 979 (85.8%) out of 1141 (high)intermediate-risk EC of women who participated in the PORTEC-1/-2 trials were available for review. Clinicopathological and molecular features were compared between MELF invasion positive and negative cases. Time-to-event analyses were done by Kaplan-Meier method, log-rank tests and Cox' proportional hazards models. RESULTS: MELF invasion was found in 128 (13.1%) cases, and associated with grade 1-2 histology, deep myometrial invasion and substantial lymph-vascular space invasion (LVSI). 85.6% of MELF invasion positive tumors were no-specific-molecular-profile (NSMP) EC. NSMP EC with MELF invasion were CTNNB1 wild type in 92.2% and KRAS mutated in 24.4% of cases. Risk of recurrence was lower for MELF invasion positive as compared to MELF invasion negative cases (4.9% vs. 12.7%, p = 0.026). However, MELF invasion had no independent impact on risk of recurrence (HR 0.65, p = 0.30) after correction for clinicopathological and molecular factors. CONCLUSIONS: MELF invasion has no independent impact on risk of recurrence in early-stage EC, and is frequently observed in low-grade NSMP tumors. Routine assessment of MELF invasion has no clinical implications and is not recommended.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. van den Heerik ASVM, Aiyer KTS, Stelloo E, et al. Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials. Gynecol Oncol. 2022. PMID: 35840357. doi:10.1016/j.ygyno.2022.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。